144 related articles for article (PubMed ID: 20651397)
21. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.
Hézode C; Duvoux C; Germanidis G; Roudot-Thoraval F; Vincens AL; Gaulard P; Cherqui D; Pawlotsky JM; Dhumeaux D
Hepatology; 1999 Sep; 30(3):775-8. PubMed ID: 10462385
[TBL] [Abstract][Full Text] [Related]
22. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
[TBL] [Abstract][Full Text] [Related]
23. Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years.
Abe T; Ichimaru N; Kokado Y; Maeda T; Kakuta Y; Okumi M; Imamura R; Nonomura N; Isaka Y; Takahara S; Okuyama A
Int J Urol; 2010 Jan; 17(1):48-54. PubMed ID: 20002504
[TBL] [Abstract][Full Text] [Related]
24. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
[TBL] [Abstract][Full Text] [Related]
25. Post-transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: report of five pediatric cases.
Lai YC; Ni YH; Jou ST; Ho MC; Wu JF; Chen HL; Hu RH; Jeng YM; Chang MH; Lee PH
Pediatr Transplant; 2006 May; 10(3):390-4. PubMed ID: 16677368
[TBL] [Abstract][Full Text] [Related]
26. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
27. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.
Knoop C; Kentos A; Remmelink M; Garbar C; Goldman S; Feremans W; Estenne M
Clin Transplant; 2006; 20(2):179-87. PubMed ID: 16640524
[TBL] [Abstract][Full Text] [Related]
28. Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study.
Buadi FK; Heyman MR; Gocke CD; Rapoport AP; Hakimian R; Bartlett ST; Sarkodee-Adoo C
Am J Hematol; 2007 Mar; 82(3):208-14. PubMed ID: 17022049
[TBL] [Abstract][Full Text] [Related]
29. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
[TBL] [Abstract][Full Text] [Related]
30. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
[TBL] [Abstract][Full Text] [Related]
31. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
[TBL] [Abstract][Full Text] [Related]
32. A single-centre experience of post-renal transplant lymphoproliferative disorder.
Herzig KA; Juffs HG; Norris D; Brown AM; Gill D; Hawley CM; Cobcroft R; Petrie JB; Marlton P; Thomson D; Campbell SB; Nicol DL; Johnson DW
Transpl Int; 2003 Jul; 16(7):529-36. PubMed ID: 12734646
[TBL] [Abstract][Full Text] [Related]
33. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
34. Development of lymphoproliferative disease after liver transplantation.
Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
[TBL] [Abstract][Full Text] [Related]
35. Rituximab in association with rapamycin for post-transplant lymphoproliferative disease treatment.
Garcia VD; Bonamigo Filho JL; Neumann J; Fogliatto L; Geiger AM; Garcia CD; Barros V; Keitel E; Bittar AE; Ferrera des Santos A; Roithmann S
Transpl Int; 2003 Mar; 16(3):202-6. PubMed ID: 12664217
[TBL] [Abstract][Full Text] [Related]
36. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
Chan TS; Hwang YY; Gill H; Au WY; Leung AY; Tse E; Chim CS; Loong F; Kwong YL
Clin Transplant; 2012; 26(5):679-83. PubMed ID: 22324300
[TBL] [Abstract][Full Text] [Related]
37. Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.
Patel H; Vogl DT; Aqui N; Shaked A; Olthoff K; Markmann J; Reddy R; Stadtmauer EA; Schuster S; Tsai DE
Leuk Lymphoma; 2007 May; 48(5):885-91. PubMed ID: 17487731
[TBL] [Abstract][Full Text] [Related]
38. Successful prolonged rituximab treatment for post-transplant lymphoproliferative disorder following living donor liver transplantation in a child.
Hayashida M; Ogita K; Matsuura T; Takahashi Y; Nishimoto Y; Ohga S; Hara T; Soejima Y; Taketomi A; Maehara Y; Kohashi K; Tsuneyoshi M; Taguchi T
Pediatr Transplant; 2007 Sep; 11(6):671-5. PubMed ID: 17663692
[TBL] [Abstract][Full Text] [Related]
39. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
40. Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.
Kremer BE; Reshef R; Misleh JG; Christie JD; Ahya VN; Blumenthal NP; Kotloff RM; Hadjiliadis D; Stadtmauer EA; Schuster SJ; Tsai DE
J Heart Lung Transplant; 2012 Mar; 31(3):296-304. PubMed ID: 22112992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]